The Faces of Luminex: Molly Frazier, Marketing

November 2nd, 2018 / Christine Valle

With Luminex’s large workforce and active marketing department, you might imagine that there are loads of ongoing projects at any one time. This could quickly lead to chaos if it weren’t for Molly Frazier, Copywriter & Marketing Coordinator, who has been keeping the trains running on time since joining the company in 2016. She earned

Continue reading »

Webinar: Multiplexed Cytokine Assays Can Explain Complex Disease

October 31st, 2018 / Hilary Graham

Cytokine and anti-cytokine patterns illuminate late-stage patient cases Scientists at Cambridge University Hospital in the UK are using Luminex xMAP® Technology to measure cytokine response, which is helpful for certain diagnoses and prognoses and can also be used to elucidate diseases with complex anti-cytokine patterns. Principal investigator Rainer Döffinger presents several case studies in this

Continue reading »

New White Paper: Molecular Testing for Gastroenteritis

October 26th, 2018 / Christine Valle

Download today for real-world clinical lab results, IDSA guideline highlights, and more If gastroenteritis testing falls under your purview, don’t miss this new white paper about how molecular testing is changing the landscape of how patients are diagnosed and treated. The paper, “Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases,” is

Continue reading »

The Faces of Luminex: Stephen Angeloni, Field Applications

October 19th, 2018 / Christine Valle

Maybe you’ve come up with a great new idea for a multiplex assay, but you need some assistance optimizing the reagents. Or perhaps you just want some training in assay design to streamline internal development. When it comes to helping customers make the most of their xMAP® Technology, Stephen Angeloni is there. As a Maryland-based

Continue reading »

Raising RSV Awareness: The ‘Minor Cold’ That Can Threaten Your Baby’s Life

October 18th, 2018 / Christine Valle

Luminex teammate Victoria Gutierrez shares her son’s fight with RSV If you have young kids, you’re probably a germ-fighting ninja during flu season. You know all about the common cold and whooping cough. But are you familiar with respiratory syncytial virus (RSV)? RSV is incredibly dangerous for little kids, but most people have never even heard

Continue reading »

MultiCode®-RTx Technology – What is it?

October 11th, 2018 / Lisa Bryan

We get a lot of questions about what exactly our MultiCode®-RTx Technology is and how it makes our ARIES® Systems sample to answer powerhouses. In a nutshell, our MultiCode-RTx is a probe-free, real-time polymerase chain reaction (PCR) technology. The technology is based on the unique MultiCode base pair isoC:isoG. Our synthetic pair differs from the

Continue reading »

The Faces of Luminex: Jill Mathias, Customer Relationship Management

October 5th, 2018 / Christine Valle

At a company the size of Luminex, even routine business processes can become very complex. We rely on Jill Mathias, CRM/Salesforce Program Manager, to keep things running smoothly when it comes to some of our key sales tools. A member of our team since 2008, she earned her bachelor’s degree in communications at St. Edward’s

Continue reading »

Webinar: Bead-Based Assays Detect Antibiotics in Livestock

October 3rd, 2018 / Christine Valle

Scientists use multiplexing technology to look for dozens of antibiotic signatures At the RIKILT institute at Wageningen University & Research in The Netherlands, the mission is “safe and reliable food for everyone” — which is why scientists are diligently developing new tests to assess the health of livestock. In this video presentation, researcher Jeroen Peters

Continue reading »

In Dublin, Reference Lab Ramps Up Respiratory Testing with NxTAG® RPP

September 27th, 2018 / Christine Valle

Multiplex assay meets throughput, turnaround time demands of a high-volume lab University College Dublin’s National Virus Reference Laboratory (UCD NVRL) isn’t just a reference lab — it also provides a primary diagnostic virology service to hospitals and general practitioners nationally. It is also a World Health Organization-designated National Influenza Centre. Each winter, testing for respiratory

Continue reading »

At the Serum Institute of India, Vaccine Development Requires Multiplex Assays

September 25th, 2018 / Hilary Graham

Bonus: Pro tips for xMAP® assay developers Since 1967, the Serum Institute of India has launched more than 20 vaccines, with five more vaccines in the pipeline specifically designed to target infectious diseases that are prevalent in developing countries. Impressively, the institute has produced more than 1.3 billion high-quality, low-cost vaccine doses. The team there

Continue reading »